Senate Aging Committee
U.S. Government: Elected Officials | U.S. Congressional Committees
Recent News About Senate Aging Committee
-
Senator Rick Scott received praise from an editorial in the Washington Reporter for his efforts addressing America's reliance on foreign-made pharmaceuticals. The article outlines recent actions led by Scott through hearings, bipartisan legislation, and committee oversight aimed at strengthening U.S. drug supply chains.
-
Senator Rick Scott joined a White House roundtable discussing ways to strengthen America's drug supply chain. He emphasized reducing reliance on foreign manufacturers through increased transparency measures like his proposed CLEAR LABELS Act.
-
Senator Rick Scott has voiced strong support for new CMS proposals intended to boost U.S.-based production of vital medical supplies amid concerns about reliance on foreign sources like China. In a detailed letter addressed Mar. 26 to CMS Administrator Dr. Mehmet Oz, Scott outlined steps he believes are needed for greater security within America's healthcare system.
-
Senator Rick Scott has introduced new legislation aimed at helping seniors stay active in the workforce without losing Social Security benefits. The announcement came during a recent Senate Aging Committee hearing focused on older Americans' role in employment.
-
Senator Rick Scott introduced new legislation aimed at removing penalties for working seniors during a recent Senate Aging Committee hearing focused on employment among older Americans. The proposal would eliminate reductions in Social Security benefits tied to earned income after retirement age.
-
The Senate Special Committee on Aging will host a hearing March 25 focusing on older Americans' roles in today's workforce. The session follows previous discussions about senior contributions across various sectors and features testimony from several experts.
-
Chairman Rick Scott and Ranking Member Kirsten Gillibrand have announced an upcoming Senate Aging Committee hearing focused on seniors' roles in America's workforce. The event will take place March 25 at the Hart Senate Office Building with expert witnesses expected.
-
Senators Rick Scott and Kirsten Gillibrand have introduced new legislation requiring country-of-origin labels for prescription drugs sold in America. Their bipartisan effort seeks greater transparency for consumers about where medicines come from.
-
Chairman Rick Scott and Ranking Member Kirsten Gillibrand highlighted their bipartisan CLEAR LABELS Act during an ABC News interview. The bill aims to require country-of-origin labeling for prescription drugs to improve transparency in the U.S. pharmaceutical supply chain.
-
Senator Rick Scott led a Senate Aging Committee hearing examining U.S. dependence on China for pharmaceuticals. The session highlighted concerns about national security and patient safety due to foreign control over essential medicine supplies.
-
Senator Rick Scott chaired a Senate Aging Committee hearing focused on U.S. reliance on China for pharmaceuticals. The session addressed legislative efforts like CLEAR LABELS aimed at improving transparency about medication origins.
-
The Senate Special Committee on Aging will hold a hearing March 11 about China's control over America's drug supply chain. Lawmakers aim to address concerns about reliance on foreign-made pharmaceuticals affecting seniors' health.
-
The Senate Special Committee on Aging will hold a hearing examining China's influence over America's drug supply chain. Lawmakers aim to address concerns about foreign dependence for essential medications used by older Americans.
-
Chairman Rick Scott and Senator Mark Kelly have introduced a bipartisan resolution to designate March 5 as National Slam the Scam Day.
-
Chairman Rick Scott’s CLEAR LABELS Act has gained support in both chambers of Congress, with Representative Rich McCormick leading the initiative in the House of Representatives.
-
Chairman Rick Scott and Ranking Member Kirsten Gillibrand of the U.S. Senate Special Committee on Aging have sent a letter to the chief executive officers of CVS, Walgreens, and Walmart.
-
Senator Rick Scott, chairman of the U.S. Senate Special Committee on Aging, led a hearing titled “From Regulator to Roadblock: How FDA Bureaucracy Stifles Innovation.” The session focused on how regulatory processes and changing standards at the...
-
Chairman Rick Scott led a hearing of the Senate Special Committee on Aging focused on how regulatory processes at the Food and Drug Administration (FDA) may delay access to treatments for rare diseases.
-
Chairman Rick Scott and Ranking Member Kirsten Gillibrand will lead a Senate Aging Committee hearing on February 26 to examine the Food and Drug Administration’s regulatory processes and their impact on patient access to innovative therapies,...
-
The Senate Special Committee on Aging will hold a hearing on February 26, 2026, to discuss the regulatory processes of the Food and Drug Administration (FDA) and their impact on patient access to therapies, especially for those with rare diseases.